Berkshire Hathaway Purchases Shares of Amgen
1 report, 1 independent
Updated Sep 22
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Berkshire Hathaway disclosed a large share purchase of Amgen on September 22, 2026. On the same day, Amgen shares gained more than 3%, a rise attributed by reports to positive Phase 3 trial results for dazodalibep, which targets moderate-to-severe Sjögren's disease in adults.
From cnbc.com
Why it matters
The purchase by a major conglomerate like Berkshire Hathaway reflects institutional interest in the biopharmaceutical sector. This type of large-scale investment can signal confidence in the long-term financial health and growth prospects of Amgen.
From cnbc.com
Who's involved
- Berkshire HathawayAmerican multinational conglomerate holding company that purchased shares
- AmgenAmerican multinational biopharmaceutical company whose shares were purchased
Keep exploring
The entities involved
-
Berkshire Hathaway
American multinational conglomerate holding company
-
Amgen
American multinational biopharmaceutical company
Related events
- Amgen and Merck are currently competing against each other in the market for investor capital.
- Warren Buffett concentrates his investments within the Berkshire Hathaway conglomerate.
- Berkshire Hathaway, guided by Warren Buffett and Charlie Munger, has invested in American Express and acquired Coca-Cola.
- Berkshire Hathaway reports Buffett's departure, VF Corp cuts dividend, and Europe increases defense investment.
- Berkshire Hathaway holds a significant stake in Bending Spoons and benchmarks it against a conglomerate's successful model.